Clinical Trial Results:
An open, multicenter, single dose, parallel study, evaluating the
pharmacokinetics of doxorubicin and its active metabolite (doxorubicinol)
after a hepatic intra-arterial injection of either a lipiodol emulsion
containing doxorubicin or doxorubicin loaded into DC Beads in patients
with intermediate stage hepatocellular carcinoma (HCC).
Summary
|
|
EudraCT number |
2013-001244-56 |
Trial protocol |
SE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
13 Feb 2025
|
First version publication date |
13 Feb 2025
|
Other versions |
|
Summary report(s) |
Summary |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.